2 recruiting. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Recruiting 2 |
Follow Benjamin Viglianti: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Groups 2, 3 & 4) Dexamethasone (Group 2), Cosyntropin (Group 3), PET/CT Scan with FNP-59 - Radiotracer, Hypertension | Early Phase 1 | Recruiting | Benjamin Viglianti | 24 | 2021-11-01 | 2025-12-05 |
| Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Group 1) FNP-59 - Radiotracer, Hypertension | Early Phase 1 | Recruiting | Benjamin Viglianti | 6 | 2021-01-18 | 2025-12-05 |
Hypertension (2)
Cosyntropin (1) · Dexamethasone (1)
United States (2)
Ben Viglianti, M.D, Ph.D. (1) · Benjamin L Viglianti, M.D, Ph.D. (1)